Legacy Education (LGCY) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Nov, 2025Company overview and business model
Operates accredited career colleges in California focused on healthcare, veterinary, business, and IT training, with three main institutions: High Desert Medical College, Central Coast College, and Integrity College of Health.
Programs emphasize real-world, job-ready skills and are strategically located near hospitals and clinics for externship and employment opportunities.
Target demographic is early to mid-20s seeking economic advancement, with a geographic focus on Southern and Central California.
Growth strategy includes expanding program offerings, launching new campuses, and pursuing acquisitions to increase national footprint.
Financial performance and metrics
Revenue for the year ended June 30, 2024, is estimated at $45.7–$46.5 million, up from $35.5 million in 2023.
Operating income for 2024 is expected to be $7.3–$8.2 million, compared to $3.6 million in 2023.
Net income for the nine months ended March 31, 2024, was $4.2 million, up 121.9% from $1.9 million in the prior year period.
As of March 31, 2024, cash and cash equivalents were $11.4 million, with total assets of $31.9 million and stockholders' equity of $19.6 million.
Student enrollment as of June 30, 2024, was 2,187, reflecting strong growth.
Use of proceeds and capital allocation
Net proceeds from the IPO will be used for facility investments, new program development, working capital, and general corporate purposes.
A portion may be allocated to acquisitions of complementary businesses, though no commitments exist at this time.
Latest events from Legacy Education
- Q2 revenue up 40.7% and net income up 46%, fueled by enrollment and program expansion.LGCY
Q2 202612 Feb 2026 - Achieved 40% revenue growth and 38% enrollment increase, driven by healthcare-focused programs and acquisitions.LGCY
Investor presentation12 Feb 2026 - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 202514 Jan 2026 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 202516 Dec 2025 - Virtual meeting to elect six directors, ratify auditor, and review governance and compensation.LGCY
Proxy Filing2 Dec 2025 - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing2 Dec 2025 - IPO targets $10.28M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - IPO seeks $10.28M to fund growth, with strong financials but high regulatory exposure.LGCY
Registration Filing29 Nov 2025 - IPO seeks up to $11.95M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025